Shareholdings
| Concept |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholdings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reporting company | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Details of specified investment shares held for purposes other than pure investment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issue |
キユーピー㈱
|
ニッコンホールディングス㈱
|
日本フエルト㈱
|
キッコーマン㈱
|
松田産業㈱
|
ミヨシ油脂㈱
|
ブルドックソース㈱
|
アルフレッサ ホールディングス㈱
|
大木ヘルスケアホールディングス㈱
|
J.フロント リテイリング㈱
|
㈱松屋
|
小野薬品工業㈱
|
MS&ADインシュアランスグループホールディングス㈱
|
㈱白洋舎
|
日本新薬㈱
|
伊藤忠食品㈱
|
㈱八十二銀行
|
片倉コープアグリ㈱
|
㈱ワコールホールディングス
|
ロート製薬㈱
|
丸八倉庫㈱
|
カンロ㈱
|
小林製薬㈱
|
久光製薬㈱
|
ウエルシアホールディングス㈱
|
㈱マルイチ産商
|
㈱ミツウロコグループホールディングス
|
わかもと製薬㈱
|
ナラサキ産業㈱
|
㈱メディパルホールディングス
|
㈱三菱UFJフィナンシャル・グループ
|
㈱T&Dホールディングス
|
㈱三井住友フィナンシャルグループ
|
㈱十八銀行
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of shares |
288,827
xbrli:shares
|
74,000
xbrli:shares
|
161,000
xbrli:shares
|
403,000
xbrli:shares
|
125,114
xbrli:shares
|
22,500
xbrli:shares
|
186,400
xbrli:shares
|
22,004
xbrli:shares
|
117,959
xbrli:shares
|
97,300
xbrli:shares
|
168,000
xbrli:shares
|
331,500
xbrli:shares
|
66,081
xbrli:shares
|
11,500
xbrli:shares
|
162,000
xbrli:shares
|
2,000
xbrli:shares
|
1,219,512
xbrli:shares
|
24,000
xbrli:shares
|
125,500
xbrli:shares
|
442,000
xbrli:shares
|
200,000
xbrli:shares
|
24,000
xbrli:shares
|
17,400
xbrli:shares
|
101,000
xbrli:shares
|
375
xbrli:shares
|
61,000
xbrli:shares
|
170,000
xbrli:shares
|
347,000
xbrli:shares
|
6,000
xbrli:shares
|
9,300
xbrli:shares
|
2,454,020
xbrli:shares
|
308,800
xbrli:shares
|
38,500
xbrli:shares
|
33,261
xbrli:shares
|
1,219,512
xbrli:shares
|
125,500
xbrli:shares
|
331,500
xbrli:shares
|
66,081
xbrli:shares
|
200,000
xbrli:shares
|
125,114
xbrli:shares
|
186,400
xbrli:shares
|
403,000
xbrli:shares
|
24,000
xbrli:shares
|
61,000
xbrli:shares
|
351
xbrli:shares
|
17,400
xbrli:shares
|
117,954
xbrli:shares
|
162,000
xbrli:shares
|
97,300
xbrli:shares
|
22,004
xbrli:shares
|
442,000
xbrli:shares
|
168,000
xbrli:shares
|
11,500
xbrli:shares
|
101,000
xbrli:shares
|
2,000
xbrli:shares
|
24,000
xbrli:shares
|
308,800
xbrli:shares
|
2,454,020
xbrli:shares
|
288,827
xbrli:shares
|
332,617
xbrli:shares
|
9,300
xbrli:shares
|
170,000
xbrli:shares
|
148,000
xbrli:shares
|
30,000
xbrli:shares
|
161,000
xbrli:shares
|
347,000
xbrli:shares
|
22,500
xbrli:shares
|
38,500
xbrli:shares
|
| Carrying amount |
766,835,000
JPY
|
193,806,000
JPY
|
73,738,000
JPY
|
2,188,290,000
JPY
|
174,283,000
JPY
|
25,267,000
JPY
|
390,321,000
JPY
|
69,312,000
JPY
|
118,785,000
JPY
|
128,144,000
JPY
|
168,672,000
JPY
|
719,023,000
JPY
|
222,692,000
JPY
|
33,637,000
JPY
|
1,305,720,000
JPY
|
9,470,000
JPY
|
559,756,000
JPY
|
27,312,000
JPY
|
345,376,000
JPY
|
1,256,164,000
JPY
|
150,200,000
JPY
|
77,160,000
JPY
|
162,516,000
JPY
|
514,090,000
JPY
|
1,410,000
JPY
|
64,111,000
JPY
|
143,820,000
JPY
|
97,507,000
JPY
|
11,274,000
JPY
|
24,459,000
JPY
|
1,349,711,000
JPY
|
359,443,000
JPY
|
149,226,000
JPY
|
91,491,000
JPY
|
695,121,000
JPY
|
386,540,000
JPY
|
1,091,961,000
JPY
|
221,701,000
JPY
|
173,400,000
JPY
|
244,848,000
JPY
|
413,808,000
JPY
|
1,724,840,000
JPY
|
81,480,000
JPY
|
62,464,000
JPY
|
1,677,000
JPY
|
133,632,000
JPY
|
199,460,000
JPY
|
1,153,440,000
JPY
|
176,015,000
JPY
|
52,105,000
JPY
|
1,314,950,000
JPY
|
253,680,000
JPY
|
35,650,000
JPY
|
832,240,000
JPY
|
11,380,000
JPY
|
29,496,000
JPY
|
521,408,000
JPY
|
1,710,451,000
JPY
|
833,843,000
JPY
|
90,804,000
JPY
|
20,274,000
JPY
|
136,680,000
JPY
|
412,920,000
JPY
|
12,060,000
JPY
|
83,398,000
JPY
|
97,507,000
JPY
|
32,400,000
JPY
|
171,633,000
JPY
|
| Purpose of shareholding |
食品分野における取引・協力関係の構築
|
流通分野における取引・協力関係の構築
|
事業展開における取引・協力関係の構築
|
食品事業を通した取引関係の維持・強化
|
食品分野における取引・協力関係の構築
|
食品分野における取引・協力関係の構築
|
食品事業を通した取引関係の維持・強化
|
販売取引関係の維持・強化
|
販売取引関係の維持・強化取引先持株会の会員としての取得により株式が増加
|
流通分野における取引・協力関係の構築
|
流通分野における取引・協力関係の構築
|
医薬品分野における取引・協力関係の構築
|
業務上の取引関係の維持・強化
|
事業展開における取引・協力関係の構築
|
医薬品分野における取引・協力関係の構築
|
販売取引関係の維持・強化
|
財務基盤の確保を踏まえた関係強化
|
事業展開における取引・協力関係の構築
|
事業展開における取引・協力関係の構築
|
医薬品分野における取引・協力関係の構築
|
流通分野における取引・協力関係の構築
|
食品分野における取引・協力関係の構築
|
医薬品分野における取引・協力関係の構築
|
医薬品分野における取引・協力関係の構築
|
販売取引関係の維持・強化取引先持株会の会員としての取得により株式が増加
|
販売取引関係の維持・強化
|
事業展開における取引・協力関係の構築
|
医薬品分野における取引・協力関係の構築
|
事業展開における取引・協力関係の構築
|
販売取引関係の維持・強化
|
財務基盤の確保を踏まえた関係強化
|
財務基盤の確保を踏まえた関係強化
|
財務基盤の確保を踏まえた関係強化
|
財務基盤の確保を踏まえた関係強化
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |